Intercell buys fellow vaccines firm Iomai in $189 million deal Austria’s Intercell is to acquire the USA’s Iomai Corp, which specialises in needle-free vaccine technology
Forest and Daiichi Sankyo end Azor co-promotion agreement Forest Laboratories has terminated its partnership with Daiichi Sankyo to co-promote the Japanese firm's antihypertensive combination treatment Azor in the USA, so it can concentrate on marketing its own products